Scientific Program

검색
Session VII (C).
Satellite Symposium (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 08:30-09:10
Chair(s) Min Ki Lee (Pusan National Univ., Korea)
Speaker
08:30-09:10
Real world treatment experience with Tepotinib in patients with METex14 skipping mutation NSCLC in Korea

Beung Chul Ahn (National Cancer Center, Korea)

Session VII (C).
Session I (A). New generation of immunotherapy (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 09:20-10:20
Chair(s) Derek Huang (National Taiwan Univ., Taiwan)
Speaker
09:20-09:40
Current standard of care with immunotherapy and clinical unmet needs

Jii Bum Lee (Yonsei Univ., Korea)

09:40-10:00
Update of CAR-T therapy in solid tumors

Hyungseok Seo (College of Pharmacy, Seoul National Univ., Korea)

10:00-10:20
Update of BiTE therapy in lung cancer

Derek Huang (National Taiwan Univ., Taiwan)

Session VII (C).
Session II (A). ADCs in thoracic oncology (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 10:35-11:35
Chair(s) Lizza E.L. Hendriks (Maastricht University Medical Centre, Netherlands)
Speaker
10:35-10:50
Current development of ADCs in thoracic oncology

Benjamin Besse (Paris-Saclay Univ., France)

10:50-11:05
Toxicities of ADCs

Yasushi Goto (National Cancer Center Hospital, Japan)

11:05-11:20
Predictive biomarkers of ADCs

Lizza E.L. Hendriks (Maastricht University Medical Centre, Netherlands)

11:20-11:35
Novel antibody-drug conjugates and new approaches

Dae Ho Lee (Univ. of Ulsan, Korea)

Session VII (C).
Plenary Session I (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 11:50-12:30
Chair(s) Jae Cheol Lee (Univ. of Ulsan, Korea)
Speaker
11:50-12:30
Biomarker driven personalized treatment of lung cancer : Best drugs first?

Benjamin Besse (Paris-Saclay Univ., France)

Session VII (C).
Luncheon Symposium I.. ROOM A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 7(Thu), 12:30-13:10
Chair(s) Dong-Wan Kim (Seoul National Univ., Korea)
Speaker
12:30-12:31
Paradigm shift for resectable NSCLC : Pembrolizumab perioperative treatment

Bin-Chi Liao (National Taiwan University Cancer Center, Taiwan)

Session VII (C).
Session III (A). Update of thymic tumors (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 13:30-14:30
Chair(s) Malgorzata Szolkowska (Institute of Tuberculosis and Lung Diseases, Poland)
Speaker
13:30-13:50
Diagnosis thymic tumors

Malgorzata Szolkowska (Institute of Tuberculosis and Lung Diseases, Poland)

13:50-14:10
Debate on complete resection in thymic tumors

Kook Nam Han (Chung-Ang Univ., Korea)

14:10-14:30
New systemic treatment in thymic tumors

Yaewon Yang (Chungbuk National Univ., Korea)

Session VII (C).
Session IV (A). Update of EGFR-mutant NSCLC (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 14:45-15:45
Chair(s) James Chih-Hsin Yang (National Taiwan Univ., Taiwan)
Speaker
14:45-15:05
Optimising first-line treatment in EGFR-mutant advanced NSCLC

Hidehito Horinouchi (National Cancer Center, Japan)

15:05-15:25
Acquired resistance mechanism in patients treated with third-generation EGFR TKIs

James Chih-Hsin Yang (National Taiwan Univ., Taiwan)

15:25-15:45
Role of ADCs in patients treated with third-generation EGFR TKIs

Yun-Gyoo Lee (Sungkyunkwan Univ., Korea)

Session VII (C).
Satellite Symposium II (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 7(Thu), 16:00-16:40
Chair(s) Sei-Hoon Yang (Wonkwang Univ., Korea)
Speaker
16:00-16:40
Session VII (C).
Session I (B). Interventional pulmonology in thoracic malignancy (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 7(Thu), 09:20-10:20
Chair(s) Neal Navani (University College London Hospital, UK)
Speaker
09:20-09:40
Advances in bronchoscopic techniques for diagnosing peripheral lung cancer

Noriaki Kurimoto (Shimane Univ., Japan)

09:40-10:00
Updates on EBUS for nodal staging and tissue acquisition

Neal Navani (University College London Hospital, UK)

10:00-10:20
Optimal management of recurrent malignant pleural effusions

Pyng Lee (National University Hospital, Singapore)

Session VII (C).
Session II (B). Treatment of lung cancer in patients with severe respiratory diseases (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 7(Thu), 10:35-11:35
Chair(s) Jeong Eun Lee (Chungnam National Univ., Korea)
Speaker
10:35-10:55
Treatment and prognosis of lung cancer in patients with severe Chronic Obstructive Pulmonary Disease (COPD)

Sei Won Lee (Univ. of Ulsan, Korea)

10:55-11:15
Postoperative acute lung injury

Kyeongman Jeon (Sungkyunkwan Univ., Korea)

11:15-11:35
Pneumonic infiltration in patients treated with immuno-oncology agents: Causes and impact on lung cancer prognosis

Cheol Kyu Park (Chonnam National Univ., Korea)

Session VII (C).
Session III (B). Management of ultra-central lung tumor (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 7(Thu), 13:30-14:30
Chair(s) Yeonsil Kim (The Catholic Univ. of Korea, Korea)
Speaker
13:30-13:50
Salvage surgery after definitive chemoradiotherapy for lung cancer

Jae Hyun Jeon (Seoul National Univ., Korea)

13:50-14:10
SBRT to ultra-central lung cancer

Sung Ho Moon (National Cancer Center, Korea)

14:10-14:30
Conventional radiotherapy for isolated lymph node metastasis after surgery or radiotherapy for lung cancer

Katsuyuki Shirai (Jichi Medical University Hospital, Japan)

Session VII (C).
Session IV (B). Optimal treatment approaches and sequential strategies for brain metastases from NSCLC (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 7(Thu), 14:45-15:45
Chair(s) Si Yeol Song (Univ. of Ulsan, Korea)
Speaker
14:45-15:00
Case presentation for brain metastases from NSCLC

Byoung Hyuck Kim (Seoul National Univ., Korea)

15:00-15:15
Systemic therapy for brain metastases from NSCLC

Beung Chul Ahn (National Cancer Center, Korea)

15:15-15:30
Stereotactic radiosurgery for brain metastases from NSCLC

Eun Jung Lee (Seoul National Univ., Korea)

15:30-15:45
Whole-brain radiation therapy for brain metastases from NSCLC

Jaeho Cho (Yonsei Univ., Korea)

Session VII (C).
Satellite Symposium II (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 7(Thu), 16:00-16:40
Chair(s) Ki Hyeong Lee (Chungbuk National Univ., Korea)
Speaker
16:00-16:40
Translating clinical trial results into real-world impact: Brigatinib case studies

Jii Bum Lee (Yonsei Univ., Korea)

Session VII (C).
Session I (C). Low-Dose computed tomography lung cancer screening: An update (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 7(Thu), 09:20-10:20
Chair(s) Eunji Choi (Weill Cornell Medicine, Cornell Univ., USA)
Speaker
09:20-09:35
Low-Dose computed tomography lung cancer screening: Real-world evidence

David Baldwin (University of Nottingham, UK)

09:35-09:50
Risk-based lung cancer screening and racial disparities in the U.S.

Eunji Choi (Weill Cornell Medicine, Cornell Univ., USA)

09:50-10:05
Low-Dose computed tomography lung cancer screening: Family history of lung cancer

Yeun-Chung Chang (National Taiwan Univ., Taiwan)

10:05-10:20
Low-Dose computed tomography lung cancer screening: AI-based risk stratification

Hyungjin Kim (Seoul National Univ., Korea)

Session VII (C).
Session II (C). Joint Symposium with HIRA (*KOR) (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 7(Thu), 10:35-11:35
Chair(s) Hye Ryun Kim (Yonsei Univ., Korea)
Speaker
10:35-10:55
Economic evaluation of new lung cancer treatments

Kookhee Kim (Health Insurance Review and Assessment Services, Korea)

10:55-11:10
Reimbursement issues in the treatment of NSCLC with rare oncogenic alterations

Shinkyo Yoon (Univ. of Ulsan, Korea)

11:10-11:25
The current reimbursement status of anti cancer agents in lung cancer patients; focusing the cases with gray zone

Min Hee Hong (Yonsei Univ., Korea)

11:25-11:35
Panel discussion

Min Hee Hong (Yonsei Univ., Korea)

Session VII (C).
Session III (C). Optimal treatment for elderly patients (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 7(Thu), 13:30-14:30
Chair(s) Chanyoot Bandidwattanawong (Navamindradhiraj Univ., Thailand)
Speaker
13:30-13:50
Surgical treatment in elderly patients: Balancing risks and benefits

Junghee Lee (Sungkyunkwan Univ., Korea)

13:50-14:10
Systemic treatment in elderly patients

Jin-Soo Kim (Seoul National Univ., Korea)

14:10-14:30
How to select the most proper treatment for the elderly lung cancer patients?

Chanyoot Bandidwattanawong (Navamindradhiraj Univ., Thailand)

Session VII (C).
Session IV (C). Oral Presentation I (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 7(Thu), 14:45-15:45
Chair(s) Yoo Duk Choi (Chonnam National Univ., Korea)
Speaker
14:45-14:55
Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression

Kwon Joong Na (Seoul National Univ., Korea)

14:55-15:05
Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy

Duk Ki Kim (Chungnam National Univ., Korea)

15:05-15:15
Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non- small cell lung cancer (NSCLC)

Jong Yeob Kim (Feinberg School of Medicine, Northwestern Univ., USA)

15:15-15:25
Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract

Joo-Eun Lee (Chungnam National Univ., Korea)

15:25-15:35
Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer

Bo-Guen Kim (Sungkyunkwan Univ., Korea)

15:35-15:45
Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity

Cheol-Kyu Park (Chonnam National Univ., Korea)

Session VII (C).
Satellite Symposium III (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 8(Fri), 08:20-09:00
Chair(s) Seung Hun Jang (Hallym Univ., Korea)
Speaker
08:20-09:00
Evolving paradigm of ALK+ mNSCLC patient treatment with Lorlatinib CROWN 5-year data

Beung Chul Ahn (National Cancer Center, Korea)

Session VII (C).
Session V (A). Small cell lung cancer recent update (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 8(Fri), 09:10-10:10
Chair(s) Takafumi Koyama (National Cancer Center, Japan)
Speaker
09:10-09:25
Molecular biology and subtype of SCLC

Sehhoon Park (Sungkyunkwan Univ., Korea)

09:25-09:40
Update of radiation in SCLC

Young Seob Shin (Univ. of Ulsan, Korea)

09:40-09:55
Recent update of systemic treatment in SCLC: Immunotherapy

Eun Joo Kang (Korea Univ., Korea)

09:55-10:10
Current status and future challenges of antibody-drug conjugates in precision oncology of SCLC

Takafumi Koyama (National Cancer Center, Japan)

Session VII (C).
Session VI (A). Immunotherapy in early-stage NSCLC (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 8(Fri), 10:25-11:25
Chair(s) Stephanie Saw Pei (National Cancer Centre Singapore, Singapore)
Speaker
10:25-10:40
Treatment strategies combining IO in high PD-L1 early-stage NSCLC

Stephanie Saw Pei (National Cancer Centre Singapore, Singapore)

10:40-10:55
Treatment strategies combining IO in low PD-L1 early-stage NSCLC

Sun Min Lim (Yonsei Univ., Korea)

10:55-11:10
Response assessment in preoperative immunotherapy

Jooae Choe (Univ. of Ulsan, Korea)

11:10-11:25
Predictive biomarker of perioperative IO treatment

Yoon La Choi (Sungkyunkwan Univ., Korea)

Session VII (C).
Luncheon Symposium II EGFR mutant positive NSCLC(Lazertinib). ROOM A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 8(Fri), 11:40-12:20
Chair(s) Young-Chul Kim (Chonnam National Univ., Korea)
Speaker
11:40-12:20
EGFR mutation positive non-small cell lung cancer

Bhumsuk Keam (Seoul National Univ., Korea)

Session VII (C).
Plenary Session II. ROOM A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 8(Fri), 12:50-13:30
Chair(s) Myung-Ju Ahn (Sungkyunkwan Univ., Korea)
Speaker
12:50-13:30
Future prospects of I-O in lung cancer management

Tony Shu Kam Mo (Chinese University of Hong Kong, Hong Kong)

Session VII (C).
Session VII (A). Treatment of NSCLC with rare mutations (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 8(Fri), 13:50-14:50
Chair(s) Sai-Hong Ignatius Ou (University of California Irvine School of Medicine, USA)
Speaker
13:50-14:05
Recent advances in HER2-mutant metastatic NSCLC

Chao-Hua Chiu (Taipei Medical Univ., Taiwan)

14:05-14:20
Advances in RET fusion-positive lung cancer

Jessica Lin (Massachusetts General Hospital, USA)

14:20-14:35
MET alterations in NSCLC; mutation, amplification, and overexpression

Ji-Youn Han (National Cancer Center, Korea)

14:35-14:50
KRAS

Sai-Hong Ignatius Ou (University of California Irvine School of Medicine, USA)

Session VII (C).
Session VIII (A). Incorporating ctDNA assays in clinical practice (A). ROOM A
(Crystal Ballroom 3)
Date & Time November 8(Fri), 15:05-16:05
Chair(s) Aadel A. Chaudhuri (Mayo Clinic, USA)
Speaker
15:05-15:20
Role of liquid biopsy in advanced NSCLC

Aaron C. Tan (National Cancer Centre Singapore (NCCS), Singapore)

15:20-15:35
Minimal residual disease: Concept, data in NSCLC

Beung Chul Ahn (National Cancer Center, Korea)

15:35-15:50
Role of liquid biopsy in monitoring adjuvant treatment: Pros

Hirotsugu Kenmotsu (Shizuoka Cancer Center, Japan)

15:50-16:05
Advances in cell-free DNA liquid biopsy for lung cancer detection and management

Aadel A. Chaudhuri (Mayo Clinic, USA)

Session VII (C).
Satellite Symposium III (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 8(Fri), 08:20-09:00
Chair(s) Jin Hyoung Kang (The Catholic Univ. of Korea, Korea)
Speaker
08:20-09:00
A new chapter in adjuvant therapy: Alectinib for resected ALK-positive NSCLC

Gyeong-Won Lee (Gyeongsang National Univ., Korea)

Session VII (C).
Session V (B). Updates on lung cancer pathology (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 8(Fri), 09:10-10:10
Chair(s) Jennifer M. Boland (Mayo Clinic, USA)
Speaker
09:10-09:30
A WHO reporting system for lung cytopathology: Standardization and clinical application

Hee Jeong Cha (Univ. of Ulsan, Korea)

09:30-09:50
Pathology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha (Yonsei Univ., Korea)

09:50-10:10
Diagnostic pitfalls on frozen section evaluation of low grade pulmonary neoplasms

Jennifer M. Boland (Mayo Clinic, USA)

Session VII (C).
Session VI (B). Updates on emerging biomarkers and technologies for lung cancer (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 8(Fri), 10:25-11:25
Chair(s) Mee Sook Roh (Dong-A Univ., Korea)
Speaker
10:25-10:45
Lung cancer screening using plasma NGS

Eunhae Cho (GC Genome, Korea)

10:45-11:05
Real-world implementation of digital pathology and AI

Junya Fukuoka (Nagasaki University Graduate School of Biomedical Sciences, Japan)

11:05-11:25
Sequencing-based classification of intrapulmonary metastasis and multiple primary lung cancer

Hyo Sup Shim (Yonsei Univ., Korea)

Session VII (C).
Session VII (B). Lung cancer surgery after neoadjuvant immunotherapy (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 8(Fri), 13:50-14:50
Chair(s) Tetsuya Mitsudomi (Kindai Univ., Japan)
Speaker
13:50-14:10
Real-world results of lung cancer surgery after neoadjuvant immunotherapy

Hong Kwan Kim (Sungkyunkwan Univ., Korea)

14:10-14:30
Defining resectability after neoadjvant immunotherapy

Tetsuya Mitsudomi (Kindai Univ., Japan)

14:30-14:50
Perioperative immune-related adverse events after neoadjuvant immunotherapy

Jang Ho Cho (The Catholic Univ. of Korea, Korea)

Session VII (C).
Session VIII (B). Surgical options for advanced lung cancer (B). ROOM B
(Crystal Ballroom 2)
Date & Time November 8(Fri), 15:05-16:05
Chair(s) Young Kwang Chae (Northwestern Univ., USA)
Speaker
15:05-15:25
Double lung transplantation in patients with advanced bilateral lung-limited non- small cell lung carcinoma

Young Kwang Chae (Northwestern Univ., USA)

15:25-15:45
Curative salvage surgery after definite CCRT

Yoichi Ohtaki (Gunma Univ., Japan)

15:45-16:05
Surgery for stage IV non-small cell lung cancer

Jae Kwang Yun (Univ. of Ulsan, Korea)

Session VII (C).
Satellite Symposium III (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 8(Fri), 08:20-09:00
Chair(s) Sang-We Kim (Univ. of Ulsan, Korea)
Speaker
08:20-09:00
Lurbinectedin in SCLC: Learning from clinical experiences

Sun Min Lim (Yonsei Univ., Korea)

Session VII (C).
Session V (C). Oral Presentation II (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 8(Fri), 09:10-10:10
Chair(s) Samina Park (Seoul National Univ., Korea)
Speaker
09:10-09:20
Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study

Junghee Lee (Sungkyunkwan Univ., Korea)

09:20-09:30
Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial

Sung Yong Lee (Korea Univ., Korea)

09:30-09:40
What is the optimal dose and fractionation schedule for inoperable node-negative large (>5 cm) non-small cell lung cancer?

Ye Jin Yoo (Univ. of Ulsan, Korea)

09:40-09:50
Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series

Young Kwang Chae (Northwestern Univ., USA)

09:50-10:00
Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer

Sangjoon Park (Yonsei Univ., Korea)

10:00-10:10
Refining patient selection for prophylactic cranial irradiation in limited-stage small- cell lung cancer: Insights from a Korean multi-institutional cohort study

Hye In Lee (Univ. of Ulsan, Korea)

Session VII (C).
Session VI (C). Oral Presentation III (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 8(Fri), 10:25-11:25
Chair(s) Shinkyo Yoon (Univ. of Ulsan, Korea)
Speaker
10:25-10:35
Real-world insights: Treatment patterns and overall survival in patient cell lung cancer in South Korea a single center experience

Sehhoon Park (Sungkyunkwan Univ., Korea)

10:35-10:45
AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients

Kwon Joong Na (Seoul National Univ., Korea)

10:45-10:55
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients

Jae Ho Cho (Chonnam National Univ., Korea)

10:55-11:05
Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1

Ji Eun Shin (The Catholic Univ. of Korea, Korea)

11:05-11:15
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer

Yang-Gun Suh (National Cancer Center, Korea)

11:15-11:25
Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: Radiomic prediction

Jihwan Choi (Sungkyunkwan Univ., Korea)

Session VII (C).
Session VII (C). 5 year Anniversary Symposium - National Lung Cancer Screening Program Part 1 (ENG) (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 8(Fri), 13:50-14:50
Chair(s) Jin Soo Lee (Health Insurance Review and Assessment Services, Korea)
Speaker
13:50-14:05
Evidence of lung cancer screening and guidelines

Seung Hun Jang (Hallym Univ., Korea)

14:05-14:20
History and achievement of world first national lung cancer screening program in Korea

Yeol Kim (National Cancer Center, Korea)

14:20-14:35
A.I. based quality control system for national lung cancer screening program

Gong Yong Jin (Jeonbuk National Univ., Korea)

14:35-14:50
Evidence for implementation of population based-lung cancer screening in Germany

Jens Vogel-Claussen (Hannover Univ., Germany)

Session VII (C).
Session VIII (C). 5 year Anniversary Symposium- National Lung Cancer Screening Program Part 2 (ENG) (C). ROOM C
(Crystal Ballroom 1)
Date & Time November 8(Fri), 15:05-16:05
Chair(s) Choon-Taek Lee (Seoul National Univ., Korea)
Speaker
15:05-15:20
Participant care and smoking cessation after lung cancer screening

Seung Won Ra (Univ. of Ulsan, Korea)

15:20-15:35
Biomarker research for enhancing effectiveness of lung cancer screening

Hilary Robbins (International Agency for Research on Cancer (IARC), France)

15:35-15:50
Expansion of target population and overdiagnosis in lung cancer screening

Jin Mo Goo (Seoul National Univ., Korea)

15:50-16:05
Panel discussion

Young-Chul Kim (Chonnam National Univ., Korea)